Table 2.
STTD P, % of NRC (2012)2–5 | ||||||
---|---|---|---|---|---|---|
Item | 80 | 90 | 100 | 115 | 130 | 150 |
Total calcium (Ca), % | ||||||
Phase 1 | 0.74 | 0.74 | 0.76 | 0.79 | 0.73 | 0.91 |
Phase 2 | 0.51 | 0.55 | 0.59 | 0.74 | 0.91 | 0.84 |
Phase 3 | 0.58 | 0.54 | 0.57 | 0.59 | 1.11 | 0.84 |
Phase 4 | 0.53 | 0.58 | 0.85 | 0.89 | 0.67 | 0.69 |
Total phosphorus (P), % | ||||||
Phase 1 | 0.40 | 0.43 | 0.47 | 0.49 | 0.56 | 0.62 |
Phase 2 | 0.31 | 0.43 | 0.48 | 0.49 | 0.57 | 0.57 |
Phase 3 | 0.33 | 0.36 | 0.36 | 0.44 | 0.46 | 0.57 |
Phase 4 | 0.31 | 0.39 | 0.48 | 0.53 | 0.54 | 0.58 |
1Representative samples of treatment diets were taken from 6 feeders per dietary treatment 3 d after the beginning and 3 d before the end of the phase and stored at −20 °C. After blending, subsamples were submitted to Ward Laboratories, Inc. (Kearney, NE) for analyses.
2Phase 1 calculated STTD P were 0.25%, 0.28%, 0.31%, 0.36%, 0.40%, and 0.46%, and calculated total P were 0.49%, 0.52%, 0.56%, 0.61%, 0.66%, and 0.73% for 80%, 90%, 100%, 115%, 130%, and 150% of the NRC (2012) estimate, respectively.
3Phase 2 calculated STTD P were 0.22%, 0.24%, 0.27%, 0.31%, 0.35%, and 0.40%, and calculated total P were 0.44%, 0.46%, 0.49%, 0.54%, 0.59%, and 0.65% for 80%, 90%, 100%, 115%, 130%, and 150% of the NRC (2012) estimate, respectively.
4Phase 3 calculated STTD P were 0.19%, 0.22%, 0.24%, 0.28%, 0.31%, and 0.36%, and calculated total P were 0.40%, 0.42%, 0.45%, 0.49%, 0.53%, and 0.59 % for 80%, 90%, 100%, 115%, 130%, and 150% of the NRC (2012) estimate, respectively.
5Phase 4 calculated STTD P were 0.17%, 0.19%, 0.21%, 0.24%, 0.27%, and 0.31%, and calculated total P were 0.37%, 0.39%, 0.42%, 0.45%, 0.49%, and 0.53% for 80%, 90%, 100%, 115%, 130%, and 150% of the NRC (2012) estimate, respectively.